Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Detinlyn is a gynecological hygiene product line marketed under the **Dermacyd** brand, primarily developed by **Sanofi**. It is formulated as a liquid intimate wash with lactic acid as its key active ingredient. The primary function of Detinlyn is to maintain or restore the natural acidic pH of the external genital mucosa, typically ranging from 3.5 to 4.5. This acidic environment is crucial for supporting the growth of beneficial microflora, such as *Lactobacillus* species, which provide a natural defense against pathogenic bacteria and fungi. Detinlyn is indicated for daily intimate hygiene to prevent irritation, odor, and discomfort while preserving the biological balance of the vaginal area. It is frequently evaluated in dermatological and gynecological clinical trials to ensure safety and lack of irritation to the mucous membranes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Detinlyn.